Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia Healthcare's EBIT per Share for the
six
months ended in Mar. 2026 was NZ$0.20.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.28.
During the past 12 months, the average EBIT per Share Growth Rate of Promisia Healthcare was 215.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 27.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Promisia Healthcare's EBIT per Share or its related term are showing as below:
NZSE:PHL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -63 Med: -21 Max: 29.4
Current: 27.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Promisia Healthcare was 29.40% per year. The lowest was -63.00% per year. And the median was -21.00% per year.
NZSE:PHL's 3-Year EBIT Growth Rate is ranked better than 69.73% of 522
companies
in the Healthcare Providers & Services industry
Industry Median: 11.95
vs NZSE:PHL: 27.40
Promisia Healthcare (NZSE:PHL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Promisia Healthcare EBIT per Share Related Terms
Promisia Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare (NZSE:PHL) has a EBIT per Share of NZ$0.28 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Promisia Healthcare and its competitors. According to the industry distribution chart, Promisia Healthcare ranks #158 out of 522 companies in the Healthcare Providers & Services industry, placing it in the top 30.3%.
Is Promisia Healthcare's EBIT per Share too high?
Promisia Healthcare's current EBIT per Share is NZ$0.28. Based on the distribution chart, Promisia Healthcare ranks #158 out of 522 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Promisia Healthcare has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #158 out of 522 companies for EBIT per Share. This puts Promisia Healthcare in the upper half of its industry. The industry median EBIT per Share is 11.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.95, based on 522 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current EBIT per Share is NZ$0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.75 — trading 78.6% above its estimated fair value. The current EBIT per Share is NZ$0.28. Promisia Healthcare's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current EBIT per Share is NZ$0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.75 is trading 78.6% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
EBIT per Share: NZ$0.28
GF Value™: NZ$0.42 vs. price of NZ$0.75 (78.6% above fair value)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
31GF Score
Get the complete analysis for NZSE:PHL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
